Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1257 of 5804
-
Can two steroids shield heart surgery patients from kidney and lung failure?
Disease control Recruiting nowCardiac surgery is a high-risk surgery and is associated with a rate of postoperative adverse outcomes. Like many others major surgery, cardiac surgery procedures induce a proinflammatory phase usually counterbalanced with an immunosuppressive phase so the immune response remaine…
Phase: PHASE3 • Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New hearing implant trial aims to help kids hear better
Disease control Recruiting nowThis study is performed to collect safety and performance data supporting the use of the Sentio system in children below 12 years of age. The system is currently available on the market for patients 12 years and above. It is a prospective study conducted at eight European hospita…
Phase: NA • Sponsor: Oticon Medical • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Ear stimulation device aims to ease chemo side effects in ovarian cancer
Symptom relief Recruiting nowImpact of stimulation of parasympathetic activity by transcutaneous auricular vagus nerve stimulation (taVNS) on quality of life (QoL) relating to digestive symptoms in patients undergoing first-line treatment for ovarian cancer, as compared to shame taVNS
Phase: PHASE3 • Sponsor: Centre Francois Baclesse • Aim: Symptom relief
Last updated Jun 27, 2026 07:54 UTC
-
New pill could tame rare genetic diabetes
Disease control Recruiting nowEvaluating a novel, allosteric glucokinase activator in monogenic diabetes secondary to inactivating glucokinase mutations: a randomised, cross-over trial
Phase: PHASE2 • Sponsor: Chinese University of Hong Kong • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
New 3D guidance system aims to sharpen kidney cancer surgery
Disease control ENROLLING_BY_INVITATIONThis study is a retrospective and prospective comparative study evaluating the efficacy, safety, and stability of the surgical navigation system 'RUS NE' in robot-assisted partial nephrectomy. The study aims to compare intraoperative and postoperative clinical indicators between …
Phase: NA • Sponsor: Hutom Corp • Aim: Disease control
Last updated Jun 26, 2026 18:46 UTC
-
New hope for Hard-to-Treat lung cancer: experimental drug combo enters trial
Disease control Recruiting nowThe purpose of this study is to determine the overall safety and tolerability of JBI-802 as single agent and in combination with Pembrolizumab.
Phase: PHASE2 • Sponsor: The Christ Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
New hope for Post-Surgery sugar crashes: avexitide trial underway
Disease control OngoingAVX-001 (LUCIDITY) is a Phase 3 study to evaluate avexitide compared to placebo in participants with post bariatric hypoglycemia (PBH) related to Roux-en-Y gastric bypass (RYGB). The study will assess avexitide compared to placebo for safety and efficacy, measured by reduction of…
Phase: PHASE3 • Sponsor: Amylyx Pharmaceuticals Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
New drug AZD4360 targets Hard-to-Treat cancers in early trial
Disease control Recruiting nowThe purpose of this study is to evaluate the safety, tolerability, PK, immunogenicity, pharmacodynamics, and preliminary efficacy of AZD4360 in adult participants with locally advanced or metastatic solid tumours selected for expression of CLDN18.2.
Phase: PHASE1, PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Could this pill clear long COVID brain fog? new trial begins
Symptom relief OngoingLong COVID is a condition where debilitating symptoms can persist for months after a COVID-19 infection. This study aims to evaluate the effects of NE3107 on several neurological symptoms reported in people with Long COVID including difficulty concentrating or remembering things …
Phase: PHASE2 • Sponsor: BioVie Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
New proton beam machine aims to improve cancer care
Disease control OngoingThis trial will enroll 47 subjects who will be be treated with the IBA PROTEUS® PLUS Proton Beam radiation Therapy (PBT) medical device. The trial aims to assess the safety and efficacy of PROTEUS® PLUS for radiation therapy to oncology patients, and to provide a clinical basis …
Phase: NA • Sponsor: Ion Beam Applications • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Antibiotics during labor may cut C-Section risk for obese Moms-to-Be
Disease control Recruiting nowObesity increases the risk of pregnancy complications, including puerperal infections and cesarean delivery, and risk rises with increasing body mass index (BMI). Since obese women are more likely to have comorbidities that would necessitate delivery prior to their due date (i.e.…
Phase: PHASE2 • Sponsor: University of Oklahoma • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Could a stronger acne drug be better for darker skin? new trial aims to find out
Disease control Recruiting nowIn Dermatology, assessment of people of color remains underrepresented in RCTs (\<10%) and guidelines. Acne affects around 9% of the population worldwide and negatively affects quality of life and self-esteem with anxiety, suicidal ideation and physical scarring. Main lesions ass…
Phase: PHASE3 • Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Could stem cells tame Alzheimer's agitation? new pilot study seeks answers
Symptom relief Recruiting nowThe purpose of this research study is to test if adding one infusion of mesenchymal stem cells to the current treatment with antipsychotic medication may help control behavioral problems in people with a diagnosis of moderate to severe Alzheimer's disease.
Phase: PHASE2 • Sponsor: Bernard (Barry) Baumel • Aim: Symptom relief
Last updated Jun 27, 2026 12:39 UTC
-
Tailored blood thinners could save limbs in PAD patients
Disease control Recruiting nowThe goal of this clinical trial is to determine whether a personalised blood clot prevention plan is more effective than standard treatment in adults with peripheral artery disease (PAD) who have undergone a procedure to restore blood flow to their legs. The main questions it ai…
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Robots teach tai chi to stroke survivors – could it boost arm recovery?
Disease control Recruiting nowThis study aims to compare the effectiveness of Robot-Assisted Tai Chi Training (RATT) versus conventional rehabilitation in improving upper limb motor function post-stroke, and to explore the neuromuscular mechanisms of RATT. Participants will be randomly assigned to one of two …
Phase: NA • Sponsor: Jing Tao • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New drug BL-M14D1 targets tough cancers in early human trial
Disease control Recruiting nowThe objective of this study is to evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of BL-M14D1 in Subjects with locally Advanced or Metastatic Small Cell Lung Cancer and Other Neuroendocrine Neoplasms
Phase: PHASE1 • Sponsor: SystImmune Inc. • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Weekly shot could replace daily needles for short kids
Disease control Recruiting nowThis is a multicenter, randomized, open-label, active-controlled Phase III clinical trial to evaluate the efficacy and safety of Inpegsomatropin injection,once a week,compared with recombinant human growth hormone (rhGH) in children with idiopathic short stature (ISS). It plans t…
Phase: PHASE3 • Sponsor: Xiamen Amoytop Biotech Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
New radioactive antibody could make sickle cell transplants safer
Disease control Recruiting nowThe purpose of this study is to find the smallest amount of the 131 I-apamistamab needed for preparing patients with severe sickle cell disease (SCD) for a bone marrow transplant. This is the first time 131 I-apamistamab is being used for advanced Sickle Cell Disease (SCD) in the…
Phase: PHASE1 • Sponsor: Columbia University • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New hope for lymphoma patients: drug combo trial aims to shrink tumors
Disease control Recruiting nowThe purpose of the study is to evaluate glofitamab + gemcitabine + oxaliplatin in participants in the United States, including under-represented racial and ethnic populations, that have relapsed or refractory (R/R) diffuse large B-cell lymphoma (DLBCL).
Phase: PHASE1 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New eczema cream shows promise in early trial
Symptom relief CompletedA multicenter, randomized, double-blind, vehicle controlled phase II clinical study
Phase: PHASE2 • Sponsor: Jiangsu vcare pharmaceutical technology co., LTD • Aim: Symptom relief
Last updated Jun 27, 2026 12:07 UTC